Cargando…

Self-Reported Hidradenitis Suppurativa Severity: Is It Useful for Clinical Practice?

INTRODUCTION: Hidradenitis suppurativa (HS) is considered to be the most burdensome dermatosis, with a well-documented negative influence on quality of life (QoL). The patient’s perception of the disorder, assessed as the self-reported severity, has been used in other dermatoses but not in HS. The a...

Descripción completa

Detalles Bibliográficos
Autores principales: Krajewski, Piotr K., Marrón, Servando E., Tomas Aragones, Lucía, Gilaberte-Calzada, Yolanda, Szepietowski, Jacek C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021336/
https://www.ncbi.nlm.nih.gov/pubmed/35274220
http://dx.doi.org/10.1007/s13555-022-00701-5
_version_ 1784689788431892480
author Krajewski, Piotr K.
Marrón, Servando E.
Tomas Aragones, Lucía
Gilaberte-Calzada, Yolanda
Szepietowski, Jacek C.
author_facet Krajewski, Piotr K.
Marrón, Servando E.
Tomas Aragones, Lucía
Gilaberte-Calzada, Yolanda
Szepietowski, Jacek C.
author_sort Krajewski, Piotr K.
collection PubMed
description INTRODUCTION: Hidradenitis suppurativa (HS) is considered to be the most burdensome dermatosis, with a well-documented negative influence on quality of life (QoL). The patient’s perception of the disorder, assessed as the self-reported severity, has been used in other dermatoses but not in HS. The aim of this study was to evaluate the usefulness of self-reported HS severity in clinical practice. METHODS: The study was performed on a group of 130 Spanish HS patients. HS severity was assessed for all the subjects. Hurley staging and patient self-reported severity were used. Moreover, QoL impairment was evaluated using the Dermatology Life Quality Index (DLQI) and the Hidradenitis Suppurativa Quality of Life 24 (HSQoL-24) questionnaire. RESULTS: The severity of HS according to the Hurley staging was most commonly assessed as Hurley II (47.7%), indicating moderate disease, followed by severe disease (Hurley III, 26.9%) and mild disease (Hurley I, 25.4%). According to the patient self-reported HS severity, most of the patients reported having mild disease (76 patients, 58.5%), followed by moderate disease (31 patients, 23.8%). Only 23 patients (17.7%) assessed their disease as severe. Moreover, men reported mild disease significantly more frequently than women (70.9% and 49.3%, respectively; p = 0.014). The self-reported HS severity correlated positively with the effect of the disease on patient QoL assessed with DLQI (r = 0.288, p < 0.001). Likewise, a strong positive correlation was found between self-reported HS severity and QoL impairment assessed with HSQoL-24 (r = 0.404, p = 0.001). No statistically significant correlation between Hurley severity stage and DLQI or HSQoL-24 was found. Moreover, there were significant differences in both DLQI and HSQoL-24 total score between different self-reported HS severities. This was not seen for any of the QoL instruments or for Hurley severity staging. CONCLUSION: The results show that self-assessment severity may reflect patients’ subjective feelings more adequately than popular objective instruments, and there should be a place for its use in daily clinical practice. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13555-022-00701-5.
format Online
Article
Text
id pubmed-9021336
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-90213362022-05-06 Self-Reported Hidradenitis Suppurativa Severity: Is It Useful for Clinical Practice? Krajewski, Piotr K. Marrón, Servando E. Tomas Aragones, Lucía Gilaberte-Calzada, Yolanda Szepietowski, Jacek C. Dermatol Ther (Heidelb) Original Research INTRODUCTION: Hidradenitis suppurativa (HS) is considered to be the most burdensome dermatosis, with a well-documented negative influence on quality of life (QoL). The patient’s perception of the disorder, assessed as the self-reported severity, has been used in other dermatoses but not in HS. The aim of this study was to evaluate the usefulness of self-reported HS severity in clinical practice. METHODS: The study was performed on a group of 130 Spanish HS patients. HS severity was assessed for all the subjects. Hurley staging and patient self-reported severity were used. Moreover, QoL impairment was evaluated using the Dermatology Life Quality Index (DLQI) and the Hidradenitis Suppurativa Quality of Life 24 (HSQoL-24) questionnaire. RESULTS: The severity of HS according to the Hurley staging was most commonly assessed as Hurley II (47.7%), indicating moderate disease, followed by severe disease (Hurley III, 26.9%) and mild disease (Hurley I, 25.4%). According to the patient self-reported HS severity, most of the patients reported having mild disease (76 patients, 58.5%), followed by moderate disease (31 patients, 23.8%). Only 23 patients (17.7%) assessed their disease as severe. Moreover, men reported mild disease significantly more frequently than women (70.9% and 49.3%, respectively; p = 0.014). The self-reported HS severity correlated positively with the effect of the disease on patient QoL assessed with DLQI (r = 0.288, p < 0.001). Likewise, a strong positive correlation was found between self-reported HS severity and QoL impairment assessed with HSQoL-24 (r = 0.404, p = 0.001). No statistically significant correlation between Hurley severity stage and DLQI or HSQoL-24 was found. Moreover, there were significant differences in both DLQI and HSQoL-24 total score between different self-reported HS severities. This was not seen for any of the QoL instruments or for Hurley severity staging. CONCLUSION: The results show that self-assessment severity may reflect patients’ subjective feelings more adequately than popular objective instruments, and there should be a place for its use in daily clinical practice. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13555-022-00701-5. Springer Healthcare 2022-03-10 /pmc/articles/PMC9021336/ /pubmed/35274220 http://dx.doi.org/10.1007/s13555-022-00701-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research
Krajewski, Piotr K.
Marrón, Servando E.
Tomas Aragones, Lucía
Gilaberte-Calzada, Yolanda
Szepietowski, Jacek C.
Self-Reported Hidradenitis Suppurativa Severity: Is It Useful for Clinical Practice?
title Self-Reported Hidradenitis Suppurativa Severity: Is It Useful for Clinical Practice?
title_full Self-Reported Hidradenitis Suppurativa Severity: Is It Useful for Clinical Practice?
title_fullStr Self-Reported Hidradenitis Suppurativa Severity: Is It Useful for Clinical Practice?
title_full_unstemmed Self-Reported Hidradenitis Suppurativa Severity: Is It Useful for Clinical Practice?
title_short Self-Reported Hidradenitis Suppurativa Severity: Is It Useful for Clinical Practice?
title_sort self-reported hidradenitis suppurativa severity: is it useful for clinical practice?
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021336/
https://www.ncbi.nlm.nih.gov/pubmed/35274220
http://dx.doi.org/10.1007/s13555-022-00701-5
work_keys_str_mv AT krajewskipiotrk selfreportedhidradenitissuppurativaseverityisitusefulforclinicalpractice
AT marronservandoe selfreportedhidradenitissuppurativaseverityisitusefulforclinicalpractice
AT tomasaragoneslucia selfreportedhidradenitissuppurativaseverityisitusefulforclinicalpractice
AT gilabertecalzadayolanda selfreportedhidradenitissuppurativaseverityisitusefulforclinicalpractice
AT szepietowskijacekc selfreportedhidradenitissuppurativaseverityisitusefulforclinicalpractice